Ridgeback Biotherapeutics
Pre-clinicalRidgeback Biotherapeutics develops potential medications to treat infectious diseases like Ebola and COVID-19. Learn more.
Founded
2015
Focus
Small Molecules
About
Ridgeback Biotherapeutics develops potential medications to treat infectious diseases like Ebola and COVID-19. Learn more.
Funding History
3Total raised: $181M
Debt$50MUndisclosedJan 15, 2022
Grant$31MU.S. Department of DefenseMay 15, 2021
Series A$100MUndisclosedMar 15, 2020
Company Info
TypePrivate
Founded2015
LocationMiami, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile